Penserra Capital Management’s Akebia Therapeutics AKBA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2021
Q4 | – | Sell |
-3,995
| Closed | -$11K | – | 1349 |
|
2021
Q3 | $11K | Buy |
3,995
+350
| +10% | +$964 | ﹤0.01% | 1342 |
|
2021
Q2 | $13K | Buy |
3,645
+165
| +5% | +$588 | ﹤0.01% | 1249 |
|
2021
Q1 | $11K | Buy |
3,480
+160
| +5% | +$506 | ﹤0.01% | 1019 |
|
2020
Q4 | $9K | Buy |
3,320
+2,100
| +172% | +$5.69K | ﹤0.01% | 928 |
|
2020
Q3 | $3K | Buy |
+1,220
| New | +$3K | ﹤0.01% | 880 |
|